Press Releases
Capsugel Announces Broad Commercial Availability of MAST™ System
Capsugel, a global leader in delivering high-quality, innovative dosage forms and solutions announced the broad commercial availability of its Modular Automated Sampling Technology™ (MAST) system, which directly transfers samples from bioreactors to analytical devices while maintaining process sterility. ...
Press Releases
Arven Pharmaceuticals selects GE Healthcare’s FlexFactory to improve Turkish and regional access to biopharmaceuticals
Arven Pharmaceuticals, a Toksoz Group Company, has selected GE Healthcare’s FlexFactory manufacturing platform to expand production capacity at its facility in Kirklareli, Turkey. With this expanded capacity, Arven will support local healthcare needs by bringing biopharmaceuticals...
Press Releases
MeiraGTx Awarded Target ALS Grant For Its NMD-Based Therapy for ALS
MeiraGTx, a New York and UK based gene therapy company, announced that it has been awarded a grant from Target ALS, a privately funded foundation bringing together a consortia of academic and biotech/pharmaceutical researchers focused on finding treatments for...
Press Releases
MDCPartners launches new ta-Scan software that ‘will revolutionize’ the way pharmaceutical companies plan for the future
MDCPartners launches ta-Scan 5, an update of its global web-based platform that analyses clinical trial data. The new platform is set to revolutionize the way pharmaceutical researchers plan for the future, by providing unrivaled insights that will help inform...
Press Releases
Cyprotex, an Evotec Company, Expands into New UK Facility at Alderley Park
Evotec AG announced that Cyprotex, a company wholly owned by Evotec AG, has completed the relocation of its UK operations from Macclesfield to Alderley Park. The move will consolidate Cyprotex’ UK operations into a single, state-of-the-art...
Press Releases
Gilead Sciences, Inc. Announces EMA Validation of Marketing Authorization Application for Investigational Chronic
Gilead Sciences, Inc announced that the company’s Marketing Authorization Application for the investigational, once-daily, single tablet regimen of sofosbuvir 400 mg. Velpatasvir 100 mg and voxilaprevir 100 mg for the treatment of chronic hepatitis C virus...
Press Releases
Takeda Recognized as one of the Global 100 Most Sustainable Corporations for second consecutive year
Takeda Pharmaceutical Company Limited ,is proud to be named by Corporate Knights to the 2017 Global 100 Most Sustainable Corporations in the World Index. Takeda achieved this distinction for the second consecutive year and it is...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read